Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug entities : Galapagos nv save search
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
Published: 2024-01-03 (Crawled : 21:00) - globenewswire.com
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 0.8%
H: 0.7%
C: -0.22%
drug collaboration
Galapagos and NovAliX enter into an integrated drug discovery collaboration
Published: 2023-03-30 (Crawled : 22:00) - biospace.com/
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 0.13%
H: 0.36%
C: -0.4%
drug collaboration
Polypeptide Therapeutic Solutions (PTS) Announces Company Name Change to Curapath and Expansion of Drug Delivery Capabilities and Services Polypeptide Therapeutic Solutions, a leader in the design, dev...
Published: 2022-10-17 (Crawled : 08:00) - biospace.com/
VRNA | $15.56 -0.19% 100K
|
Health Technology
|
| O: 2.1%
H: 2.74%
C: 1.17%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 2.32%
H: 0.92%
C: 0.22%
ALKS | $24.54 1.15% 260K
|
Health Technology
|
| O: 0.4%
H: 2.42%
C: 1.81%
expansion drug solutions services change
New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight
Published: 2022-07-26 (Crawled : 16:00) - prnewswire.com
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: -0.17%
H: 0.48%
C: 0.17%
SNY | News | $46.82 -1.82% 510K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
IMAB | $1.805 0.28% 31K
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: -1.61%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: -1.81%
H: 2.67%
C: 2.16%
BIIB | $202.7 4.93% 1.6M
|
Health Technology
|
| O: -0.42%
H: 3.54%
C: 2.01%
drug companies therapeutics
Galapagos In-licenses Novel Drug Targets for Inflammatory Bowel Disease Discovered by Scipher Medicine’s Spectra™ Platform
Published: 2022-05-24 (Crawled : 15:00) - biospace.com/
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 0.76%
H: 0.16%
C: -0.75%
drug disease platform license
Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: -2.97%
H: 2.56%
C: 1.65%
fibrosis positive drug preclinical cudetaxestat pre-clinical
FDA Crackdown on JAK Drug Class Unwelcome News for Pharma Giants
Published: 2021-09-02 (Crawled : 18:00) - biospace.com/
ABBV | News | $168.51 -0.61% 920K
|
Health Technology
|
| O: 1.14%
H: 0.17%
C: -1.35%
INCY | $51.4 -0.48% 380K
|
Health Technology
|
| O: 0.23%
H: 0.65%
C: 0.03%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 2.59%
H: 1.24%
C: 0.81%
fda drug pharma
Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase III Study
Published: 2021-05-20 (Crawled : 15:00) - biospace.com/
BDX | $234.225 -0.06% 330K
|
Health Technology
|
| O: -0.41%
H: 1.51%
C: 1.3%
MIST | $1.645 -3.24% 19K
|
Health Technology
|
| O: -0.37%
H: 2.21%
C: 0.18%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 0.19%
H: 2.85%
C: 2.1%
russia drug
Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase I...
Published: 2021-05-20 (Crawled : 14:00) - biospace.com/
BDX | $234.225 -0.06% 330K
|
Health Technology
|
| O: -0.41%
H: 1.51%
C: 1.3%
MIST | $1.645 -3.24% 19K
|
Health Technology
|
| O: -0.37%
H: 2.21%
C: 0.18%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 0.19%
H: 2.85%
C: 2.1%
russia drug
Global Roundup: UK-Developed RA Drug Shows Significant Promise in Phase III S...
Published: 2021-05-20 (Crawled : 13:00) - biospace.com/
BDX | $234.225 -0.06% 330K
|
Health Technology
|
| O: -0.41%
H: 1.51%
C: 1.3%
MIST | $1.645 -3.24% 19K
|
Health Technology
|
| O: -0.37%
H: 2.21%
C: 0.18%
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: 0.19%
H: 2.85%
C: 2.1%
drug
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Published: 2021-04-23 (Crawled : 05:00) - globenewswire.com
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: -1.29%
H: 0.79%
C: 0.1%
new drug treatment drug therapy ulcerative colitis
OXURION NV to Present at Wet AMD and DME Drug Development Summit
Published: 2021-04-13 (Crawled : 06:00) - globenewswire.com
GLPG | News | $29.01 -1.49% 59K
|
Health Technology
|
| O: -1.15%
H: 2.55%
C: 2.35%
BCYC | $22.62 -0.27% 440K
|
Health Technology
|
| O: 0.11%
H: 8.58%
C: 8.44%
drug dmd
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.